This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Patients with acute pulmonaryembolism (PE) have a wide spectrum of clinical presentations, from incidental findings to sudden cardiac death. Here, we propose an algorithm where the role of the PulmonaryEmbolism Response Team (PERT) is reinforced. PROSPERO registration number: CRD42024493303.
BACKGROUND:Prior clinical trials have demonstrated the efficacy of ultrasound-facilitated catheter-directed thrombolysis (USCDT) for the treatment of acute intermediate-risk pulmonaryembolism (PE) using reduced thrombolytic doses and shorter infusion durations. Circulation: Cardiovascular Interventions, Ahead of Print.
In this case report, we demonstrated that thrombus aspiration and in situ thrombolysis through the Guidezilla GEC are applicable to patients with PE in whom systemic thrombolysis is contraindicated, resulting in successful reperfusion and positive clinical outcomes.
Surgical pulmonary artery thrombectomy is a well-established emergency treatment for massive pulmonaryembolism (PE) in which fibrinolysis or thrombolysis are not effective. However, surgery for massive PE tha.
Findings from the first international randomized controlled trial to compare patient outcomes following treatment with large-bore mechanical thrombectomy (LBMT) versus catheter-directed thrombolysis (CDT) for intermediate-risk pulmonaryembolism (PE) show that LBMT is superior with respect to the hierarchically-tested aggregated outcome of all-cause (..)
The goal of the trial was to compare the efficacy and safety of large-bore mechanical thrombectomy (LBMT) with catheter-directed thrombolysis (CDT) in the treatment of intermediate-high risk pulmonaryembolism (PE).
Introduction Multiple abnormal electrocardiographic findings have been documented in patients experiencing acute pulmonaryembolism. To date, only a limited number of cases involving a complete atrioventricular block have been reported in acute pulmonaryembolism.
Genetic protein S (PS) deficiency caused by PROS1 gene mutation is an important risk factor for hereditary thrombophilia.Case introductionIn this case, we report a 28-year-old male patient who developed a severe pulmonaryembolism during his visit. The patient was diagnosed with acute pulmonaryembolism and pneumonia.
BACKGROUND:The aim of this study was to examine the impact of early versus delayed catheter-based therapies (CBTs) on clinical outcomes in patients with acute intermediate-risk pulmonaryembolism (PE).METHODS:This years; 44% women; 29% catheter-directed thrombolysis; 68% mechanical thrombectomy; and 3% both).
Background:The role of advanced therapies (systemic thrombolysis, catheter-based treatment, and surgical thrombectomy) for the management of right heart thrombus is poorly defined. 0.99]) and concurrent pulmonaryembolism (odds ratio, 5.36 [95% CI, 2.48–12.1]) Circulation: Cardiovascular Interventions, Ahead of Print.
The usefulness of JVP in a cardiac emergency like acute pulmonaryembolism may appear superfluous. In these situations, the humble neck veins can assist us in the decision to thrombolysis or the need for any newer intrapulmonary Interventions under RV assist system. One such thought is described in this animation.
Women and black patients were less frequently treated with minimally invasive therapy compared to men or non-Black patients, according to new data from the REAL-PE analysis which investigated catheter-based pulmonaryembolism (PE) treatment. Late-breaking results from the study, for which Sahil A.
recently announced new data that demonstrate patients with intermediate-risk pulmonaryembolism (PE) treated with Penumbra’s computer assisted vacuum thrombectomy (CAVT) technology have a shorter length of hospital stay, shorter post-procedure length of stay and fewer complications compared to other treatment options.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content